bpc 157 human clinical trial gastric ulcer Stable Pentadecapeptide as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System Stable Gastric Pentadecapeptide BPC 157
Description
Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits bacterial growth and allows multiple withdrawals from the same vial over up to 28 days
Jayaraj, Azimullah, Beiram, Jalal, & Rosenberg, 2019)
Pain Reduction: This peptide effectively decreases pain in damaged areas, offering relief for those suffering from muscle sprains, tears, and other injuries
Food and Drug Administration (FDA) for the diagnosis, treatment, cure, or prevention of any disease
The solution may still be usable, but future reconstitutions should use gentle swirling only
